These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37400776)

  • 1. Hepatitis C Virus in people with experience of injection drug use following their displacement to Southern Ukraine before 2020.
    Yakovleva A; Kovalenko G; Redlinger M; Smyrnov P; Tymets O; Korobchuk A; Kotlyk L; Kolodiazieva A; Podolina A; Cherniavska S; Antonenko P; Strathdee SA; Friedman SR; Goodfellow I; Wertheim JO; Bortz E; Meredith L; Vasylyeva TI
    BMC Infect Dis; 2023 Jul; 23(1):446. PubMed ID: 37400776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phylodynamics and migration data help describe HIV transmission dynamics in internally displaced people who inject drugs in Ukraine.
    Kovalenko G; Yakovleva A; Smyrnov P; Redlinger M; Tymets O; Korobchuk A; Kolodiazieva A; Podolina A; Cherniavska S; Skaathun B; Smith LR; Strathdee SA; Wertheim JO; Friedman SR; Bortz E; Goodfellow I; Meredith L; Vasylyeva TI
    PNAS Nexus; 2023 Mar; 2(3):pgad008. PubMed ID: 36896134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.
    Solomon SS; Mehta SH; Srikrishnan AK; Solomon S; McFall AM; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Lucas GM; Kumar MS; Sulkowski MS; Quinn TC
    Lancet Infect Dis; 2015 Jan; 15(1):36-45. PubMed ID: 25486851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating HIV and HCV prevalence among people who inject drugs in 5 Ukrainian cities using stratification-based respondent driven and random sampling.
    Zelenev A; Shea P; Mazhnaya A; Meteliuk A; Pykalo I; Marcus R; Fomenko T; Prokhorova T; Altice FL
    Int J Drug Policy; 2019 May; 67():91-101. PubMed ID: 30503695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of direct and indirect social and spatial ties in the diffusion of HIV and HCV among people who inject drugs: a cross-sectional community-based network analysis in New Delhi, India.
    Clipman SJ; Mehta SH; Srikrishnan AK; Zook KJ; Duggal P; Mohapatra S; Shanmugam S; Nandagopal P; Kumar MS; Ogburn E; Lucas GM; Latkin CA; Solomon SS
    Elife; 2021 Aug; 10():. PubMed ID: 34342266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
    Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
    BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study.
    Akiyama MJ; Cleland CM; Lizcano JA; Cherutich P; Kurth AE
    Lancet Infect Dis; 2019 Nov; 19(11):1255-1263. PubMed ID: 31540840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatiotemporal Phylodynamics of Hepatitis C Among People Who Inject Drugs in India.
    Clipman SJ; Mehta SH; Rodgers MA; Duggal P; Srikrishnan AK; Saravanan S; Balakrishnan P; Vasudevan CK; Ray SC; Kumar MS; Quinn TC; Cloherty GA; Lucas GM; Solomon SS
    Hepatology; 2021 Oct; 74(4):1782-1794. PubMed ID: 34008172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with phylogenetic clustering of hepatitis C among people who inject drugs in Baltimore.
    Falade-Nwulia O; Hackman J; Mehta SH; McCormick SD; Kirk GD; Sulkowski M; Thomas D; Latkin C; Laeyendecker O; Ray SC
    BMC Infect Dis; 2020 Nov; 20(1):815. PubMed ID: 33167892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis.
    Solomon SS; McFall AM; Lucas GM; Srikrishnan AK; Kumar MS; Anand S; Quinn TC; Celentano DD; Mehta SH
    PLoS Med; 2017 Nov; 14(11):e1002460. PubMed ID: 29182638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatiotemporal Reconstruction of the Introduction of Hepatitis C Virus into Scotland and Its Subsequent Regional Transmission.
    McNaughton AL; Cameron ID; Wignall-Fleming EB; Biek R; McLauchlan J; Gunson RN; Templeton K; Tan HM; Leitch EC
    J Virol; 2015 Nov; 89(22):11223-32. PubMed ID: 26311892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
    Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF
    BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar.
    Khatib A; Matiko E; Khalid F; Welty S; Ali A; Othman A; Haji S; Dahoma M; Rutherford G
    BMC Public Health; 2017 Nov; 17(1):917. PubMed ID: 29183287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C prevalence and key population size estimate updates in San Francisco: 2015 to 2019.
    Facente SN; Grinstein R; Bruhn R; Kaidarova Z; Wilson E; Hecht J; Burk K; Grebe E; Morris MD
    PLoS One; 2022; 17(5):e0267902. PubMed ID: 35544483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).
    Scheibe A; Young K; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Puren A; Hausler H
    BMC Infect Dis; 2020 Sep; 20(1):655. PubMed ID: 32894072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C among vulnerable populations: A seroprevalence study of homeless, people who inject drugs and prisoners in London.
    Aisyah DN; Shallcross L; Hayward A; Aldridge RW; Hemming S; Yates S; Ferenando G; Possas L; Garber E; Watson JM; Geretti AM; McHugh TD; Lipman M; Story A
    J Viral Hepat; 2018 Nov; 25(11):1260-1269. PubMed ID: 29851232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics associated with HIV and hepatitis C seroprevalence among sexual and injecting partners of HIV positive persons who inject drugs in Nairobi and coastal Kenya.
    Sambai BC; Kingston H; Monroe-Wise A; Mbogo L; Juma E; Ludwig-Barron N; Guthrie BL; Bukusi D; Chohan BH; Scott J; Bosire R; Dunbar M; Macharia P; Masyuko S; Sinkele W; Herbeck JT; Farquhar C
    BMC Infect Dis; 2022 Jan; 22(1):73. PubMed ID: 35062890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 and hepatitis C virus selection bottleneck in Chinese people who inject drugs.
    Li F; Ma L; Feng Y; Ruan Y; Hu J; Song H; Liu P; Ma J; Rui B; Kerpen K; Scheinfeld B; Srivastava T; Metzger D; Li H; Bar KJ; Shao Y
    AIDS; 2018 Jan; 32(3):309-320. PubMed ID: 29194114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of and risk factors for hepatitis C virus antibody among people who inject drugs in Cambodia: a national biological and behavioral survey.
    Yi S; Mun P; Chhoun P; Chann N; Tuot S; Mburu G
    Harm Reduct J; 2019 Apr; 16(1):29. PubMed ID: 31036011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing and scaling up HCV treatment services for people who inject drugs and other high risk groups in Ukraine: An evaluation of programmatic and treatment outcomes.
    Mazhnaya A; Meteliuk A; Barnard T; Zelenev A; Filippovych S; Altice FL
    Int J Drug Policy; 2017 Sep; 47():187-195. PubMed ID: 28811159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.